Jump to content
RemedySpot.com

Links to 6 New HCV Articles

Rate this topic


Guest guest

Recommended Posts

Guest guest

Outcomes Differ Among Hepatitis C-Related Vasculitides

Doctors Lounge

Among patients with hepatitis C virus-related vasculitis, those with

polyarteritis nodosa have a more severe and acute clinical presentation and a

higher rate of clinical remission, according to a study published online Feb.

....

New drug combo for hepatitis C shows promise

STLtoday.com

Dr. Bruce R. Bacon, hepatitis C and liver cancer specialist at St. Louis

University, examines patient Bloebaum of Troy, Ill. ( S.

Cordle/PD) Researchers at St. Louis University have been testing a new drug that

could increase the cure ...

Minnesota nurse may have stolen painkillers, infected patients

Reuters

There was no evidence that blood-borne pathogens such as Hepatitis B, Hepatitis

C or HIV were transmitted to the patients who suffered from bacterial

infections, it said. The hospital tested all patient-controlled IV bags

containing painkillers for ...

See all stories on this topic »

Achillion wins patent for anti-hepatitis compound

Hartford Business

By Seay New Haven drug developer Achillion Pharmaceuticals Inc. says its

new US patent covering a key compound in its treatment for hepatitis C protects

it while undergoing clinical trials to bring the drug to market but also widens

the door to ...

See all stories on this topic »

Clinical Trial on Hepatitis C Holds Promise For Patients

MedIndia

by on March 17, 2011 at 9:28 AM A clinical trial of a new Hepatitis

C therapy has shown that it could potentially reduce treatment time, with fewer

side effects than existing drugs. The side effects of existing treatments are so

severe ...

See all stories on this topic »

Patients of suspended doctor advised to speak with personal physicians

Las Vegas Review - Journal

On Tuesday, Dr. Lawrence Sands, chief health officer of the Southern Nevada

Health District, said patients who underwent prostate biopsies by Kaplan could

be at risk for blood-borne diseases that include HIV and hepatitis C. The

prostate biopsy ...

See all stories on this topic »

Link to comment
Share on other sites

Guest guest

Outcomes Differ Among Hepatitis C-Related Vasculitides

Doctors Lounge

Among patients with hepatitis C virus-related vasculitis, those with

polyarteritis nodosa have a more severe and acute clinical presentation and a

higher rate of clinical remission, according to a study published online Feb.

....

New drug combo for hepatitis C shows promise

STLtoday.com

Dr. Bruce R. Bacon, hepatitis C and liver cancer specialist at St. Louis

University, examines patient Bloebaum of Troy, Ill. ( S.

Cordle/PD) Researchers at St. Louis University have been testing a new drug that

could increase the cure ...

Minnesota nurse may have stolen painkillers, infected patients

Reuters

There was no evidence that blood-borne pathogens such as Hepatitis B, Hepatitis

C or HIV were transmitted to the patients who suffered from bacterial

infections, it said. The hospital tested all patient-controlled IV bags

containing painkillers for ...

See all stories on this topic »

Achillion wins patent for anti-hepatitis compound

Hartford Business

By Seay New Haven drug developer Achillion Pharmaceuticals Inc. says its

new US patent covering a key compound in its treatment for hepatitis C protects

it while undergoing clinical trials to bring the drug to market but also widens

the door to ...

See all stories on this topic »

Clinical Trial on Hepatitis C Holds Promise For Patients

MedIndia

by on March 17, 2011 at 9:28 AM A clinical trial of a new Hepatitis

C therapy has shown that it could potentially reduce treatment time, with fewer

side effects than existing drugs. The side effects of existing treatments are so

severe ...

See all stories on this topic »

Patients of suspended doctor advised to speak with personal physicians

Las Vegas Review - Journal

On Tuesday, Dr. Lawrence Sands, chief health officer of the Southern Nevada

Health District, said patients who underwent prostate biopsies by Kaplan could

be at risk for blood-borne diseases that include HIV and hepatitis C. The

prostate biopsy ...

See all stories on this topic »

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...